dexmedetomidine nasal spray + dexmedetomidine hydrochloride nasal spray blank preparation
Phase 2/3UNKNOWN 0 watching 0 views this week📈 Rising
65
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Preoperative Sedation
Conditions
Preoperative Sedation
Trial Timeline
May 31, 2020 → Sep 10, 2021
NCT ID
NCT04383418About dexmedetomidine nasal spray + dexmedetomidine hydrochloride nasal spray blank preparation
dexmedetomidine nasal spray + dexmedetomidine hydrochloride nasal spray blank preparation is a phase 2/3 stage product being developed by Jiangsu Hengrui Medicine for Preoperative Sedation. The current trial status is unknown. This product is registered under clinical trial identifier NCT04383418. Target conditions include Preoperative Sedation.
Hype Score Breakdown
Clinical
22
Activity
15
Company
10
Novelty
7
Community
8
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04383418 | Phase 2/3 | UNKNOWN |
Competing Products
2 competing products in Preoperative Sedation
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| SHR0302 Base Gel + SHR0302 Base Gel Placebo | Jiangsu Hengrui Medicine | Phase 1 | 33 |
| Dexmedetomidine hydrochloride nasal spray + Dexmedetomidine hydrochloride nasal spray blank preparation. | Jiangsu Hengrui Medicine | Phase 1 | 33 |